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care delivered. Our study does have limitations because our findings
arise from a single center. Also, we did not evaluate the equivalent
ICD-10 code (Z66 “Do-not-resuscitate”) that is now largely used,
though prior studies have demonstrated a similar performance
between equivalent ICD-9 and ICD-10 codes (11–13). Given the
observed performance characteristics, we recommend that the
V49.86 code be used for studies designed to capture the general
epidemiology of patients with DNR status (e.g., evaluating secular
trends and variation in DNR orders). However, given that
administrative data cannot reliably determine timing of DNR status
within a hospitalization, this code should not be used for risk
adjustment within a hospitalization, though prior DNR may be used
for risk adjustment in longitudinal studies.
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Interpretation of Spirometry in Saskatchewan
First Nations Adults
To the Editor:
The Canadian First Nations and Inuit communities bear a large
burden of respiratory disease, with increased rates of smoking,
respiratory infections, asthma, chronic obstructive lung disease,
and hospitalizations (1). Identification of respiratory disease and
classification has relied on spirometric reference values from
white individuals, or in the case of the Global Lung Initiative
(GLI) dataset, “other” (2), because there are no published
reference values for Canadian First Nations individuals. Several
studies have suggested that spirometric values for Canadian
Inuit populations may be different from those for white
populations (3–7), but these observations are not consistent
(7–10). This study investigated whether lung function measured
in Plains Cree adults differed from that expected in white adults.
Part of the data reported in this letter was presented at the
2014 American Thoracic Society International Conference in
abstract form (11).
Methods
We conducted a voluntary survey of Saskatchewan Plains Cree adults
aged 18 years and older. Exclusion criteria were physician diagnosis
of lung disease, current respiratory infection, dialysis, congestive
heart failure, and inability to perform spirometry. Those reporting
respiratory diseases were included if there was no spirometric
evidence of obstruction or restriction and no current symptoms.
Spirometry was performed using an Easy on-PC spirometer
(ndd Medical Technologies, Inc.) following American Thoracic
Society/European Respiratory Society guidelines (12). Forced
expiratory volume in 1 second (FEV1), forced vital capacity (FVC),
and flow–volume graphs were reviewed and graded separately (13)
by two readers (M.E.F. and B.L.G.) to exclude unusable results.
z-Scores were calculated using the 2012 GLI spirometric reference
equations for white individuals (2).
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Statistical analysis. Descriptive statistics were used to
compare GLI z-scores with the expected distribution (mean, 0;
standard deviation [SD], 1). The relationship of z-scores for each
spirometry outcome to age and body mass index (BMI) was
assessed using a simple linear regression. Two subgroup analyses
were conducted.
Ethics approval process. A research agreement was developed
with Battle River Treaty 6 Health Centre using accepted principles
(14) and signed after approval by the Battlefords Tribal Council,
leadership representing Poundmaker Cree Nation, Little Pine
First Nation, Red Pheasant First Nation, Mosquito Grizzly Bear’s
Head First Nation, Sweetgrass First Nation, Mossomin First
Nation, and Lucky Man First Nation.
Results
Demographics. A total of 412 participants (266 female) were
enrolled, representing approximately 13% of adults. Spirometry
was performed in 392 (95%) participants, 324 (82.6%) of whom
had usable FEV1 and FVC data and met inclusion criteria. Of these,
88% were current or former smokers, and 81% were overweight
(BMI, .25 kg/m2).
Mean z-scores for FEV1, FVC, and FEV1/FVC were all
within the 0.5 z-score limits for white individuals, indicating good
overall fit (15) (Table 1), with 5.6%, 4.6%, and 4.0% of observations
below the lower limit of normal for FEV1, FVC, and FEV1/FVC,
respectively (Figure 1). z-Scores significantly decreased with
increasing age for zFEV1 (fitted line slope, 20.02; 95% confidence
interval,20.02,20.01) and zFVC (20.02;20.03,20.01), whereas
they increased with increasing age for zFEV1/FVC (0.004; 20.001,
0.01). z-Scores significantly decreased with increasing BMI for
zFEV1 (20.03; 20.04, 0.01) and zFVC (20.04; 20.05, 20.02),
whereas they increased with increasing BMI for zFEV1/FVC (0.02;
0.006, 0.03).
Subgroup analyses. In a subgroup of nonsmokers without a
history of respiratory disease (n = 38), the average z-scores were
lower for our First Nations population than for white individuals
(mean [SD] values of zFEV1, 20.35 [1.3]; zFVC, 20.25 [1.1];
zFEV1/FVC, 20.28 [0.9]). Sixty-one percent had a BMI greater
than or equal to 30 kg/m2. In a second subgroup analysis, adults
younger than 55 years of age with a BMI greater than 18 kg/m2
and less than 30 kg/m2 (n = 138) had zFEV1 and zFVC values
above zero (0.21 [1.0] and 0.32 [0.9], respectively) and FEV1/FVC
values below zero (20.24 [0.8]). Furthermore, z-sores for
FVC and FEV1 in this subgroup were independent of age and
BMI.
Discussion
When using the GLI reference equations, the predicted values
for white individuals are currently the most appropriate for our
First Nations study population. Our results suggest that lung
volumes may be underestimated in this population; however,
the high rates of smoking and obesity in the general population
make it challenging to identify a cohort of “healthy” individuals.
The lower z-scores in asymptomatic nonsmokers are likely due
to the “healthy smoker effect” because smoking is endemic
(16). The next best approximation of a healthy population was
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Figure 1. z-Score histograms for forced expiratory volume in 1 second (FEV1; left panel), forced vital capacity (FVC; center panel), and FEV1/FVC ratio (right
panel) for all 334 participants who had usable FEV1 and FVC data and met inclusion criteria. The mean (standard deviation) values were as follows: FEV1,
20.06 (1.08); FVC, 0.00 (1.00); and FEV1/FVC, 20.18 (0.78).
Table 1. Summary of the study participants with acceptable
spirometry results who met inclusion criteria
n All Female Male
Sex 324 63% 37%
Age, yr 324 41.16 14.7 41.76 13.4 40.26 16.8
Height, cm 324 1696 8.9 1646 6.3 1776 6.3
Weight, kg 324 87.86 20.6 84.66 18.8 93.26 22.5
BMI, kg/m2 324 30.76 7.1 31.36 7.2 29.66 6.7
,25 19% 17% 22%
>25 to ,30 30% 26% 38%
>30 to ,35 27% 30% 20%
>35 25% 27% 21%
Questionnaire
Smoking 313 87.9% 87.8% 88.0%
Disease* 322 29.5% 27.7% 32.5%
mMRC >3 319 17.6% 19.5% 14.3%
Spirometry
zFEV1 324 20.06 (1.1) 20.02 (1.0) 20.13 (1.2)
zFVC 324 0.00 (1.0) 0.03 (0.9) 20.03 (1.1)
zFEV1/FVC 324 20.18 (0.8) 20.15 (0.7) 20.23 (0.9)
Definition of abbreviations: BMI = body mass index; mMRC=modified
Medical Research Council dyspnea scale; zFEV1 = z-score for forced
expiratory volume in 1 second; zFEV1/FVC = z-score for ratio of forced
expiratory volume in 1 second to forced vital capacity; zFVC = z-score for
forced vital capacity.
Note: Not all questionnaire data were completed by all participants.
*Self-reported history of a respiratory disease.
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the second subgroup analysis of younger, nonobese adults,
who showed a trend toward lung volumes larger than in
white individuals, even though 90% were current or former
smokers.
The observed results have clinical implications for the
diagnosis of restrictive lung disease. The use of GLI predicted
values for white individuals in First Nations populations may
underestimate the early phases of lung volume decline in restrictive
lung diseases, potentially delaying diagnosis/intervention.
Resolving this question definitively remains a vital issue in the
clinical assessment of First Nations patients to avoid misclassification
of disease.
In addition, we observed a likely cohort effect and
accelerated lung function decline with aging. A previous study
observed similar associations in Inuit populations (17). We
speculate that there is a “multiple-hit” causality whereby an
integration of exposures and illness, such as environmental
exposures (smoke, poor housing), high prevalence of smoking,
and high rates of childhood and adult respiratory tract
infections, may explain this accelerated loss. In particular, 5.3%
of the population reported a history of tuberculosis, which
has been associated with long-term lung function impairment
(18) and has been proposed as a cause of age-related accelerated
decline in lung function (17). Furthermore, other infections
(e.g., childhood respiratory syncytial virus [19]) may also play
a role.
Limitations. Recruitment for the present study was nonrandom,
occurring during working hours, introducing potential selection
bias. The demographic and sociodemographic characteristics of
this population (88% current/former smokers, 52% obese, and
64% with a history of respiratory diseases or symptoms) make
it challenging to select a representative sample of healthy
individuals. Nonsmokers may not have normal lung function and
may choose to avoid smoking for health reasons—the “healthy
smoker effect” (16). Typically, random samples of healthy
nonsmokers larger than 150 males and 150 females are required to
validate reference equations for a population (15), which was not
feasible in this study. Our results are applicable among Plains Cree
First Nations populations and may have limited applicability to other
Aboriginal groups (20).
Conclusions. Until more data are available, we recommend using
the “Caucasian” ethnicity for GLI reference values, rather than
“Other,” for interpretation of spirometry in Plains Cree adults. This
study suggests that lung volumes in First Nations people may be
higher than in white individuals, and more studies are required
to establish this difference and derive appropriate prediction
equations if necessary.
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